This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

HCP0613

Hanmi Pharmaceutical Co., Ltd.

Drug Names(s): mosapride/Bacillus subtilis/Streptococcas feacium

Description: HCP0613 is a fixed-dose combination of mosapride (Gasmotin), Bacillus subtilis, and Streptococcas feacium.


HCP0613 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug